Researchers find a promising alternative to Ozempic using AI

Date:

Share this article:

Del denne artikel:

Artificial intelligence is playing an increasingly significant role in drug development.

Novo Nordisk has entered into a collaboration with OpenAI to use artificial intelligence in the development of new medicines, according to the media outlet Il Fatto Alimentare.

The goal is both to discover new compounds and to make production more efficient, following previous issues with medicine supply.

The agreement comes at a time when competition in the obesity drug market is intensifying.

According to analyses, the market could reach very high valuations over the next ten years.

Also read: This is how much water you should drink every day

The company has previously implemented major cost-cutting measures, highlighting that the industry is undergoing change.

Technology in research

Researchers from Stanford Medicine have also used artificial intelligence to study how the body regulates appetite, publishing their findings in Nature.

They have identified a new peptide that can influence appetite without the side effects often seen in current treatments.

The research was based on existing knowledge of hormones that affect blood sugar and hunger.

Also read: These dreams recur among dying patients at night

Using a computer program, the scientists analyzed thousands of potential molecules.

They then tested the most promising candidates in the laboratory on brain cells that control hunger and satiety.

This method made it possible to identify relevant candidates more quickly than traditional approaches.

Animal trials

The most promising results were subsequently tested on animals such as mice and pigs.

Also read: How brazil nuts can affect your body if you eat them every day

These trials showed a significant reduction in food intake and an improvement in the body’s metabolism.

No clear side effects were observed in the experiments. At the same time, analyses indicated that the compound works differently from existing medications.

Sources: Il Fatto Alimentare, Stanford Medicine, and Nature.

Also read: New study: Naps may be linked to increased mortality

Also read: Pregnant women’s blood may reveal children’s risk of asthma

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

Taking Ozempic or Wegovy? The FDA just added a vision-loss warning to the label

Behind the label change is a single eye condition and a rate that quietly doubled compared with the trials' control groups.

Five breathing techniques that may calm anxiety in just a few minutes

All five patterns have research behind them, but one stood out for how fast it works.

How eating tomatoes every day may affect your heart and cancer risk

A cheap kitchen staple keeps showing up in major heart and cancer reviews, and the daily amount is smaller than you'd expect.

What your gums can reveal about your heart health and disease risk

What a dentist spots at your next checkup may say something about the blood vessels around your heart, not just about your teeth.

Taking Ozempic or Wegovy? The FDA just added a vision-loss warning to the label

Behind the label change is a single eye condition and a rate that quietly doubled compared with the trials' control groups.

Five breathing techniques that may calm anxiety in just a few minutes

All five patterns have research behind them, but one stood out for how fast it works.

How eating tomatoes every day may affect your heart and cancer risk

A cheap kitchen staple keeps showing up in major heart and cancer reviews, and the daily amount is smaller than you'd expect.